Vitrolife AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,440	3,609	3,512	3,234	1,681
Revenue Growth (YoY)	-4.68%	2.76%	8.60%	92.38%	34.96%
Cost of Revenue	1,443	1,470	1,534	1,454	635
Gross Profit	1,997	2,139	1,978	1,780	1,046
Selling, General & Admin	1,318	1,232	1,117	1,002	503
Research & Development	118	117	127	143	114
Other Operating Expenses	-13	-2	-4	-12	-
Operating Expenses	1,423	1,347	1,240	1,133	617
Operating Income	574	792	738	647	429
Interest Expense	-69	-94	-94	-44	-10
Interest & Investment Income	16	24	16	2	1
Currency Exchange Gain (Loss)	-22	-30	-64	-34	41
Other Non Operating Income (Expenses)	-12	-14	-5	-16	-1
EBT Excluding Unusual Items	487	678	591	555	460
Merger & Restructuring Charges	-15	-	-	-	-
Impairment of Goodwill	-	-	-4,250	-	-
Gain (Loss) on Sale of Assets	-	-4	-3	-23	-
Asset Writedown	-5,357	-	-50	-	-
Pretax Income	-4,885	674	-3,712	537	460
Income Tax Expense	127	160	139	143	116
Earnings From Continuing Operations	-5,012	514	-3,851	394	344
Minority Interest in Earnings	-	-1	-	-	-3
Net Income	-5,012	513	-3,851	394	341
Net Income to Common	-5,012	513	-3,851	394	341
Net Income Growth	-	-	-	15.54%	18.88%
Shares Outstanding (Basic)	135	135	135	135	115
Shares Outstanding (Diluted)	135	136	135	135	115
Shares Change (YoY)	-0.07%	0.09%	-	18.12%	5.60%
EPS (Basic)	-37.01	3.79	-28.44	2.91	2.97
EPS (Diluted)	-37.01	3.78	-28.44	2.91	2.97
EPS Growth	-	-	-	-2.18%	12.58%
Free Cash Flow	460	815	690	585	359
Free Cash Flow Per Share	3.40	6.01	5.10	4.32	3.13
Dividend Per Share	1.100	1.100	1.000	0.850	0.800
Dividend Growth	-	10.00%	17.65%	6.25%	-
Gross Margin	58.05%	59.27%	56.32%	55.04%	62.22%
Operating Margin	16.69%	21.95%	21.01%	20.01%	25.52%
Profit Margin	-145.70%	14.21%	-109.65%	12.18%	20.29%
Free Cash Flow Margin	13.37%	22.58%	19.65%	18.09%	21.36%
EBITDA	942	1,168	1,107	991	506
EBITDA Margin	27.38%	32.36%	31.52%	30.64%	30.10%
D&A For EBITDA	368	376	369	344	77
EBIT	574	792	738	647	429
EBIT Margin	16.69%	21.95%	21.01%	20.01%	25.52%
Effective Tax Rate	-	23.74%	-	26.63%	25.22%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.